Evidence map›Paper›PMID 39409188›Full record

ArticleInternational journal of molecular sciences2024

Chemokine Receptor N-Terminus Charge Dictates Reliance on Post-Translational Modifications for Effective Ligand Capture and Following Boosting by Defense Peptides.

Ting Xu, Anne Sophie Schou, Jarkko J Lackman, Marina Barrio-Calvo, Lisa Verhallen, Christoffer Knak Goth, Benjamin Anderschou Holbech Jensen, Christopher T Veldkamp, Brian F Volkman, Francis C Peterson and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ting XuDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0009-0004-5666-1032
Anne Sophie SchouDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0009-0000-9618-3478
Jarkko J LackmanCopenhagen Center for Glycomics, University of Copenhagen, 2200 Copenhagen, Denmark.
Marina Barrio-CalvoDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-8783-4336
Lisa VerhallenDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-5998-2446
Christoffer Knak GothDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Benjamin Anderschou Holbech JensenDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0001-6991-0828
Christopher T VeldkampDepartment of Chemistry, University of Wisconsin-Whitewater, Whitewater, WI 53190, USA.
Brian F VolkmanDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Francis C PetersonDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Gertrud Malene HjortøDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-0057-6371

Funding

Structural Basis for Chemokine FunctionR01AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI VOLKMAN, BRIAN F · 2004 to 2019
$4.1M
Structural Basis for Chemokine FunctionR37AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI Brian F Volkman · 2020 to 2026
$2.8M
NIAID NIH HHS R01 AI058072NIAID NIH HHS R37 AI058072NIH HHS AI058072Research Foundation - Flanders 11P7Q24N , V471323N
6 · The paper itself

Abstract

The chemokine receptors CCR1 and CCR5 display overlapping expression patterns and ligand dependency. Here we find that ligand activation of CCR5, not CCR1, is dependent on N-terminal receptor O-glycosylation. Release from O-glycosylation dependency is obtained by increasing CCR5 N-terminus acidity to the level of CCR1. Ligand activation of CCR5, not CCR1, drastically improves in the absence of glycosaminoglycans (GAGs). Ligand activity at both CCR1 and CCR5 is boosted by positively charged/basic peptides shown to interact with acidic chemokine receptor N-termini. We propose that receptors with an inherent low N-terminus acidity rely on post-translational modifications (PTMs) to efficiently compete with acidic entities in the local environment for ligand capture. Although crucial for initial ligand binding, strong electrostatic interactions between the ligand and the receptor N-terminus may counteract following insertion of the ligand into the receptor binding pocket and activation, a process that seems to be aided in the presence of basic peptides. Basic peptides bind to the naked CCR1 N-terminus, not the CCR5 N-terminus, explaining the loss of boosting of ligand-induced signaling via CCR5 in cells incapable of glycosylation.

Indexed as

PeptidesProtein Processing, Post-TranslationalReceptors, CCR1Receptors, CCR5AnimalsGlycosaminoglycansGlycosylationHumansLigandsProtein BindingCCR1 protein, humanCCR5 protein, humanGlycosaminoglycansLigandsPeptidesReceptors, CCR1Receptors, CCR5CCR1CCR5chemokineelectrostatic interactionglycosaminoglycanO-glycosylationpost-translational modificationreceptor N-terminussignalingtyrosine sulfation

Identifiers

PMID39409188
PMCPMC11477141

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.